27 February 2008
The effect of 30 Hz vs. 50 Hz passive vibration and duration of vibration on skin blood flow in the arm
Colleen Maloney-HindsABCDEF, Jerrold Scott PetrofskyABCDEF, Grenith ZimmermanACDEMed Sci Monit 2008; 14(3): CR112-116 :: ID: 836575
Abstract
Background
Recently, researchers have demonstrated that Whole Body Vibration (WBV) results in significant increases in skin blood flow (SBF). No study has determined if a specific frequency or a specific duration is better at optimizing SBF.
Material and Method
Two studies were conducted to determine, 1) if there is a difference in SBF due to passive vibration of the forearm at 30 Hz vs. 50 Hz, 2) if one frequency is superior, and 3) if there is an optimal duration. In the first study, 18 subjects (mean age 20.3+/-2.9 years) were randomly placed into a 30 Hz or 50 Hz vibration group, and in the second, seven subjects (mean age 23.3+/-3.8 years) participated in both 30 and 50 Hz vibration. Each subject's arm was passively vibrated for 10 minutes. SBF was examined during vibration and for 15 minutes of recovery.
Results
Both frequencies produced significant increases in SBF (p<0.05) within the first four minutes of vibration. Peak SBFs were obtained by the fifth minute. SBF remained high for minutes 4 through 10 of vibration in the second study. In the first study, SBF remained high for minutes 4 through 9. During recovery, 30 Hz vibration produced SBFs below baseline values while 50 Hz SBFs remained above baseline. Statistically one frequency was not superior to the other.
Conclusions
Five minutes of 30 Hz or 50 Hz vibration produced significant increases in SBF. Clinically, 50 Hz has additional benefits because SBF increased more rapidly and did not result in vasoconstriction during the recovery period. Future studies should be done to determine if these increases in SBF could be of benefit to populations with low circulation such as those with diabetes.
Keywords: Skin - blood supply, Regional Blood Flow, Vibration, Arm - blood supply, Adolescent
Editorial
01 July 2026 : Editorial
Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development AcceleratesDOI: 10.12659/MSM.954627
Med Sci Monit 2026; 32:e954627
In Press
Clinical Research
Impact of Treatment Modality on Pain, Sexual Function, and Psychological Well-Being in Patients With Bartho...Med Sci Monit In Press; DOI: 10.12659/MSM.952422
Clinical Research
Association Between Radiographic Knee Osteoarthritis, Pre-Fracture Mobility, and Hip Fracture Patterns in O...Med Sci Monit In Press; DOI: 10.12659/MSM.952678
Clinical Research
Association Between Total Cholesterol–to–High-Density Lipoprotein Ratio and Gestational Hypertension: A Cas...Med Sci Monit In Press; DOI: 10.12659/MSM.952395
Review article
Clinical Use of Endotracheal Intubation Without Neuromuscular Blockade: The Current Stage of KnowledgeMed Sci Monit In Press; DOI: 10.12659/MSM.951765
Most Viewed Current Articles
17 Jan 2024 : Review article 14,176,136
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,757,712
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,466,132
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 708,784
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






